Viral Infections & Cognitive Function: Memory, Attention & Beyond

The lingering effects of viral infections on cognitive function – often described as “brain fog” – have become increasingly apparent since the COVID-19 pandemic. But the phenomenon isn’t new. Researchers are now deepening our understanding of how viruses can disrupt mental clarity, attention, and memory, extending investigations beyond SARS-CoV-2 to include infections like HIV, herpes, and hepatitis. A recent review of 931 papers has identified specific immune signatures associated with this post-viral cognitive dysfunction, offering potential avenues for diagnosis and treatment.

Immune Exhaustion and Persistent Cognitive Symptoms

The review, published in April 2026 in Clinical Immunology, highlights a common thread across different viral infections: immune dysfunction. Specifically, the research points to exhausted CD4+ T cells – a type of white blood cell crucial for coordinating the immune response – as a key factor in the development of post-viral brain fog. This exhaustion appears to impair the body’s ability to clear the virus effectively and may also contribute to chronic inflammation, both of which can negatively impact brain function. The study focused on individuals with HIV, finding that those with incomplete immune recovery (CD4+ cell counts below 500 cells/μL and a CD4/CD8 ratio less than 0.4) exhibited reduced stem cell-like memory T cell responses to the SARS-CoV-2 vaccine, alongside increased expression of immune checkpoint molecules. Read the full study here.

Stem cell-like memory T cells (TSCM) are particularly important because of their ability to self-renew and generate other immune cells, providing long-term protection. When these cells are compromised, the immune system’s ability to respond to future threats – including vaccines – is diminished. The researchers also found an enrichment of T peripheral exhausted cells (TPEX) in both CD4+ and CD8+ compartments in those with low CD4+ counts, further indicating immune dysfunction.

HIV and COVID-19 Vaccine Response

The connection between HIV and impaired COVID-19 vaccine response is particularly noteworthy. People living with HIV (PLWHIV) often experience weakened immune systems, making them more vulnerable to infections and less responsive to vaccination. The study suggests that immune exhaustion in PLWHIV may contribute to a reduced ability to generate a robust immune response to the COVID-19 vaccine, potentially increasing their risk of severe illness and long-term cognitive effects. This is consistent with broader observations about the impact of chronic infections on vaccine efficacy.

Beyond COVID-19: A Wider Pattern of Viral Impact

Even as the recent surge in research is driven by the COVID-19 pandemic, the link between viral infections and cognitive impairment has been recognized for some time. The impact of COVID-19 on people living with HIV-1 has been a specific area of concern, with potential for cumulative neurological manifestations, particularly in those who have progressed to HIV-1-associated neurocognitive disorders (HAND). Learn more about the impact of COVID-19 on PLWHIV. Herpes viruses, including Epstein-Barr virus (EBV), have also been implicated in chronic fatigue syndrome and other conditions associated with cognitive dysfunction. Similarly, hepatitis C virus (HCV) infection has been linked to cognitive decline and an increased risk of dementia.

The common denominator appears to be chronic immune activation and inflammation. Viruses can trigger a sustained immune response that, over time, can damage brain cells and disrupt neuronal connections. This can lead to a range of cognitive symptoms, including problems with memory, attention, concentration, and executive function.

What Does This Mean for Individuals Experiencing Brain Fog?

It’s important to emphasize that experiencing cognitive difficulties after a viral infection is not uncommon. However, the underlying causes can be complex and varied. The identification of specific immune signatures, as highlighted in the recent review, offers hope for more targeted diagnostic and therapeutic approaches. Currently, there are no specific treatments for post-viral brain fog, but management strategies focus on symptom relief and supportive care. These may include cognitive rehabilitation, lifestyle modifications (such as regular exercise and a healthy diet), and addressing any underlying medical conditions.

The study also suggests that interventions aimed at restoring immune function, such as GSK3β inhibition (which showed promise in restoring TCF-1 in CD4+ TSCM/TCM cells in the study), may have the potential to improve cognitive outcomes. However, further research is needed to determine the safety and efficacy of these approaches.

Evaluating Cognitive Function in PLWHIV

Ongoing research is also focused on evaluating cognitive function in specific populations, such as people living with HIV. A prospective observational study conducted at “Laiko” General Hospital aimed to assess cognitive function in PLWHIV both before and after COVID-19 infection. Read more about this study here. These types of studies are crucial for understanding the long-term impact of viral infections on cognitive health and for developing effective interventions.

The Path Forward: Research and Surveillance

The findings from this review and related studies underscore the demand for continued research into the mechanisms underlying post-viral cognitive dysfunction. Future studies should focus on identifying biomarkers that can predict who is at risk of developing long-term cognitive problems and on developing targeted therapies to prevent or treat these conditions. Improved surveillance systems are also needed to track the prevalence of post-viral cognitive impairment and to monitor the effectiveness of interventions.

Public health agencies are continually reviewing data and updating guidance as new information becomes available. Individuals experiencing persistent cognitive symptoms after a viral infection should consult with a qualified healthcare professional for evaluation and management. It’s also important to stay informed about official public health updates and recommendations.

Next Steps: Researchers are planning larger-scale clinical trials to evaluate the efficacy of immune-modulating therapies for post-viral brain fog. These trials will aim to determine whether restoring immune function can improve cognitive outcomes and quality of life for individuals affected by this debilitating condition. The results of these trials are expected to inform future clinical guidelines and treatment recommendations.